Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2022
/
Article
/
Fig 1
/
Research Article
Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB
Figure 1
ROC of NLR, dNLR, LDH, LMR, PAB, and ALB.
(a)
(b)
(c)
(d)
(e)
(f)